🇮🇳 Peptide Regulations in India

Legal Status

India regulates pharmaceuticals under the Drugs and Cosmetics Act, 1940, and its associated rules. The CDSCO, headed by the Drugs Controller General of India (DCGI), oversees drug approvals, manufacturing licences, and import permits. India is one of the world's largest manufacturers of pharmaceutical peptides and active pharmaceutical ingredients (APIs). Many peptides are manufactured in India for export to global markets. For domestic sale, peptides intended for therapeutic use require marketing approval. Research chemicals are less strictly regulated, and in vitro research peptides are widely available from Indian chemical suppliers. India's regulatory framework has undergone significant reform in recent years, with the New Drugs and Clinical Trials Rules 2019 modernising the approval process.

Compounding Rules

• Compounding is permitted under Schedule K of the Drugs and Cosmetics Rules for pharmacies operating under a drug licence.
• Hospital pharmacies may prepare in-house formulations for patients under the supervision of a registered pharmacist.
• Large-scale manufacturing of peptides requires a drug manufacturing licence from the state Drug Controller.
• India's bulk pharmaceutical manufacturing capacity means many peptides are available as APIs from licenced manufacturers.
• The Indian Pharmacopoeia Commission (IPC) publishes monographs and quality standards for pharmaceutical substances.
• Contract research organisations (CROs) in India can procure research peptides under their institutional licences.

Personal Importation

• Personal importation of drugs into India is not well-codified — the Drugs and Cosmetics Act focuses primarily on commercial importation.
• Import of drugs for personal use is generally tolerated in small quantities, particularly for drugs not available domestically.
• Commercial importation of drugs requires an import licence from the CDSCO and registration of the product.
• Indian customs may inspect pharmaceutical imports, but enforcement of personal-use imports is inconsistent.
• Narcotic and psychotropic substances are strictly controlled under the NDPS Act — separate permits are required.

How to Verify Legality

• Search the CDSCO's approved drugs database at cdsco.gov.in.
• Check the Indian Pharmacopoeia for monographs and quality standards.
• Verify manufacturer licences through the state Drug Controller's office.
• Look for WHO-GMP certification or ISO 9001 certification for quality assurance.
• Consult the CDSCO's list of banned and restricted drugs.